These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

812 related articles for article (PubMed ID: 17319104)

  • 1. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome.
    Hadi HA; Carr CS; Al Suwaidi J
    Vasc Health Risk Manag; 2005; 1(3):183-98. PubMed ID: 17319104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial dysfunction in obesity: etiological role in atherosclerosis.
    Meyers MR; Gokce N
    Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):365-9. PubMed ID: 17940464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction and hypertension in diabetes mellitus.
    Dandona P; Chaudhuri A; Aljada A
    Med Clin North Am; 2004 Jul; 88(4):911-31, x-xi. PubMed ID: 15308385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifestyle modification and endothelial function in obese subjects.
    Hamdy O
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthy endothelium: the scientific basis for cardiovascular health promotion and chronic disease prevention.
    Mensah GA
    Vascul Pharmacol; 2007 May; 46(5):310-4. PubMed ID: 17229594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endothelium in health and in cardiovascular disease.
    Garćia-Palmieri MR
    P R Health Sci J; 1997 Jun; 16(2):136-41. PubMed ID: 9285990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effects after withdrawal of simvastatin on brachial artery endothelial function in patient with coronary heart disease or risk factors].
    Chen H; Ren JY; Wu B; Liu X; Wang RJ; Li LJ; Luo Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jun; 35(6):531-5. PubMed ID: 17711713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial function as an end-point in interventional trials: concepts, methods and current data.
    Lüscher TF; Noll G
    J Hypertens Suppl; 1996 Sep; 14(2):S111-9; discussion S119-21. PubMed ID: 8934387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive evaluation of endothelial function.
    Bae JH
    J Cardiol; 2001; 37 Suppl 1():89-92. PubMed ID: 11433834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome.
    Otani H
    Antioxid Redox Signal; 2011 Oct; 15(7):1911-26. PubMed ID: 21126197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current perspective. Diabetic vascular disease: from endothelial dysfunction to atherosclerosis.
    Candido R; Zanetti M
    Ital Heart J; 2005 Sep; 6(9):703-20. PubMed ID: 16212072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial dysfunction in metabolic and vascular disorders.
    Polovina MM; Potpara TS
    Postgrad Med; 2014 Mar; 126(2):38-53. PubMed ID: 24685967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound assessment of endothelial function in children.
    Järvisalo MJ; Raitakari OT
    Vasc Health Risk Manag; 2005; 1(3):227-33. PubMed ID: 17319108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options.
    Britten MB; Zeiher AM; Schächinger V
    J Intern Med; 1999 Apr; 245(4):315-27. PubMed ID: 10356593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of diabetes mellitus on endothelial dysfunction.
    Varughese GI
    South Med J; 2007 Feb; 100(2):128-9. PubMed ID: 17330677
    [No Abstract]   [Full Text] [Related]  

  • 16. [Value of endothelial dysfunction in cardiovascular diseases and methods of its correction with drugs].
    gidullin NSh; Valeeva KF; Gassanov N; Zagidullin ShZ
    Kardiologiia; 2010; 50(5):54-60. PubMed ID: 20831049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelium-dependent and independent vasodilation studies at normoglycaemia in type I diabetes mellitus with and without microalbuminuria.
    Dogra G; Rich L; Stanton K; Watts GF
    Diabetologia; 2001 May; 44(5):593-601. PubMed ID: 11380077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial function: a surrogate endpoint in cardiovascular studies?
    Frick M; Weidinger F
    Curr Pharm Des; 2007; 13(17):1741-50. PubMed ID: 17584104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus.
    Otsuki M; Goya K; Kasayama S
    Vasc Health Risk Manag; 2005; 1(3):209-15. PubMed ID: 17319106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-angiotensin system inhibitor and statins combination therapeutics - what have we learnt?
    Koh KK; Sakuma I; Hayashi T; Kim SH; Chung WJ
    Expert Opin Pharmacother; 2015 May; 16(7):949-53. PubMed ID: 25747324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.